UroGen Pharma has opened another front in its attack on bladder cancer, paying IconOVir Bio $4 million in stock for an ...

“Partnering with Genesis Therapeutics presents a unique opportunity to leverage their AI technologies to accelerate the ...

Illumina is raising the curtain on its upcoming entry into spatial transcriptomics, with tech designed to help researchers ...

On Jan. 2, Hookipa inked a non-binding agreement that would have created a merged company with Poolbeg via an all-stock ...

The wearable cardiac monitor maker VitalConnect has raised $100 million in new capital to aid in the development of its ...

BioMed X Institute is teaming up with the Barbados government in an effort to accelerate cardiometabolic treatments for ...